303 related articles for article (PubMed ID: 34774219)
1. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study.
Kaur G; Chauhan AS; Prinja S; Teerawattananon Y; Muniyandi M; Rastogi A; Jyani G; Nagarajan K; Lakshmi P; Gupta A; Selvam JM; Bhansali A; Jain S
Lancet Public Health; 2022 Jan; 7(1):e65-e73. PubMed ID: 34774219
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.
Nguyen TP; Wright EP; Nguyen TT; Schuiling-Veninga CC; Bijlsma MJ; Nguyen TB; Postma MJ
PLoS One; 2016; 11(5):e0155699. PubMed ID: 27192051
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
5. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.
Hoerger TJ; Harris R; Hicks KA; Donahue K; Sorensen S; Engelgau M
Ann Intern Med; 2004 May; 140(9):689-99. PubMed ID: 15126252
[TBL] [Abstract][Full Text] [Related]
6. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
7. Decision tree-Markov model of perinatal depression screening: a cost-utility analysis.
Yang Y; Zheng R; Yang L; Huang X; Zhang T
Front Public Health; 2024; 12():1308867. PubMed ID: 38832225
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
[TBL] [Abstract][Full Text] [Related]
11. Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway.
Henkel PS; Burger EA; Sletner L; Pedersen K
Med Decis Making; 2024 May; 44(4):380-392. PubMed ID: 38591188
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of implementing a decentralised Hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India.
Muniyandi M; Tyagi K; Singh M; Prakash V; Karikalan N; Senthilkumar S; Karthikeyan S; Krishnan R; Rajsekar K; Shanmugam V; Selvavinayagam TS
Trop Med Int Health; 2021 Mar; 26(3):374-384. PubMed ID: 33190357
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.
Nayagam S; Conteh L; Sicuri E; Shimakawa Y; Suso P; Tamba S; Njie R; Njai H; Lemoine M; Hallett TB; Thursz M
Lancet Glob Health; 2016 Aug; 4(8):e568-78. PubMed ID: 27443782
[TBL] [Abstract][Full Text] [Related]
14. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
16. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
Okubo R; Kondo M; Hoshi SL; Yamagata K
Sleep Breath; 2015 Sep; 19(3):1081-92. PubMed ID: 25643768
[TBL] [Abstract][Full Text] [Related]
19. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany.
König HH; Barry JC
Pediatrics; 2004 Feb; 113(2):e95-108. PubMed ID: 14754978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
